November 19, 2019 – West Palm Beach, FL – Integra Connect, the leading provider of technologies and services for value-based specialty care, today announced it has been selected by the Quality Cancer Care Alliance Network (QCCA), the first clinically integrated nationwide network of community oncology practices, as its preferred partner for population health analytics technology and to provide support for value-based care payment models.
As a QCCA preferred partner, Integra Connect will offer QCCA’s network of 20 community-based oncology practices access to Integra Connect Intelligence – Integra’s comprehensive suite of population health analytics solutions. These tools will enable the oncology practices to precisely assume risk for each episode of care and will empower the practices to achieve both clinical and financial objectives under value-based care. Specifically, Integra’s population health solutions will provide QCCA members with:
Clinical analytics: provides deeper insights into patient treatment patterns, variations in care, adherence to clinical guidelines and measurement of outcomes, based on real-world evidence
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
Predictive analytics: applies machine learning techniques to proactively identify high-risk patients for whom intervention and care management initiatives can reduce adverse events and improve outcomes
Quality measurement: enables quality improvement initiatives, tracking and reporting of quality measures across the QCCA network
Financial analytics: measures and tracks financial performance under Alternative Payment Models (APM) across both commercial and government programs, like the Oncology Care Model (OCM), and supports management of risk under the two-sided risk models
Network benchmarking: enables QCCA members to track their performance over time and compare with their peers at a national level across an array of metrics, from practice treatment patterns to high-cost utilization trends, quality measures and outcomes
“We are committed to providing our member oncology practices with the resources necessary to comply with the ever-evolving value-based payment reform initiatives for oncology and to continually improve quality and efficiency of care across our integrated network of practices,” said Sibel Blau, MD, CEO of QCCA. “We have found a true partner in Integra Connect as they share our vision and mission of supporting oncology practices so they not only survive but also thrive under value based care models all while ensuring the advancement of oncological innovation.”